Conditions: Asthma
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 385
Healthy volunteers: no

Brief summary:
Open label, 12-week clinical trial to assess efficacy, safety, treatment adherence and Quality of Life impact of Mometasone Furoate dry powder 400 mcg once-daily in persistent mild-moderate asthmatic patients at least 12 years old.

Protocol deviations may have occurred that resulted in quality issues associated with reporting of the data.

Detailed description:

Arms:
arm 1: Mometasone Furoate 400 mcg once daily in the evening through 12 weeks.

Interventions: intervention 1: Mometasone Furoate
Intervention descriptions: intervention 1: Mometasone Furoate 400 mcg once daily, in the evening through 12 weeks.

Protocol document: